New and emerging treatments for irritable bowel syndrome and functional dyspepsia.

about

The 5-HT3 receptor as a therapeutic target Existing and emerging therapies for irritable bowel syndrome.Relationship of functional gastrointestinal disorders and psychiatric disorders: implications for treatment.

P2860

Q24681066-54F927C0-4089-42E1-B9E9-E7ED108CBAE3 Q37857849-A634A402-4DE6-45AE-BF9D-8BBF725B9F94 Q43135087-F37B1C38-FD04-42FF-AA47-4C7364A5B4A8

P2860

New and emerging treatments for irritable bowel syndrome and functional dyspepsia.

Item

http://www.wikidata.org/entity/Q46576618

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

New and emerging treatments for irritable bowel syndrome and functional dyspepsia.

@en

New and emerging treatments for irritable bowel syndrome and functional dyspepsia.

@nl

type

Item

label

New and emerging treatments for irritable bowel syndrome and functional dyspepsia.

@en

New and emerging treatments for irritable bowel syndrome and functional dyspepsia.

@nl

prefLabel

New and emerging treatments for irritable bowel syndrome and functional dyspepsia.

@en

New and emerging treatments for irritable bowel syndrome and functional dyspepsia.

@nl

P1476

New and emerging treatments for irritable bowel syndrome and functional dyspepsia.

@en

P2093

Nicholas J Talley

http://www.w3.org/2001/XMLSchema#string

P2860

Misoprostol in the treatment of chronic refractory constipation: results of a long-term open label trial.

Evidence-based data on pain relief with antidepressants.

Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder.

Management of the irritable bowel syndrome.

Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome.

Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome

Muscarinic antagonists in development for disorders of smooth muscle function.

Hypersensitivity and hyperreactivity in the irritable bowel syndrome: An opportunity for drug discovery.

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial.

Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis.

P304

91-98

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728214.7.1.91

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15989538

http://www.w3.org/2001/XMLSchema#string

New and emerging treatments for irritable bowel syndrome and functional dyspepsia.

about

P2860

P2860

New and emerging treatments for irritable bowel syndrome and functional dyspepsia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698